ARTICLE | Company News
Stellar, Matritech bladder diagnostic deal
October 24, 2003 7:00 AM UTC
Canadian specialty pharma company Stellar (TSE:YYS; SLRXF) received exclusive rights to market NMPS's NMP22 BladderChek test to diagnose and monitor bladder cancer. BladderChek is approved by FDA for ...